This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Self-destructive Behavior
Information about Self-destructive Behavior: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Self-destructive Behavior
Most recent studies have shown that Self-destructive Behavior shares some biological mechanisms with antisocial-personality-disorder, anxiety-disorders, borderline-personality-disorder, cancer-patients-and-suicide-and-depression, depressive-disorder, eating-disorders, mental-disorders, personality-disorders, psychotic-disorders, schizophrenia, stress-psychological, substance-related-disorders.
Among the many pathways, these few ones have gauged particular interests from scientists studying Self-destructive Behavior, and have been seen in publications frequently: Adult Behavior, Aging, Amino Acid Activation, Brain Development, Cognition, Developmental Process, Drug Resistance, Eating Behavior, Enucleation, Hypersensitivity, Menstruation, Operant Conditioning, Parental Behavior, Pathogenesis, Saliva Secretion, Secretion, Social Behavior
Quite a number of genes have been found to play important roles in Self-destructive Behavior, such as BDNF, CCK, CHAT, CSF2, CSH1, DCX, ERCC8, HPRT1, HSPA9, INS, KIF22, LAMC2, MRPL28, PITX3, PRL, SH2D3C, TH. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.